Emerging Nano-Theranostic Strategies Against Non-Alcoholic Fatty Liver Disease: A review
محل انتشار: مجله علم مواد و مهندسی ایران، دوره: 20، شماره: 1
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 167
فایل این مقاله در 28 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJMSEI-20-1_004
تاریخ نمایه سازی: 6 خرداد 1402
چکیده مقاله:
As a major global cause of liver disease, non-alcoholic fatty liver disease (NAFLD) is characterized by excessive hepatocellular accumulation of lipids in the liver, elevated levels of hepatic enzymes, and fibrotic evidence. The primary therapies for NAFLD are changing lifestyle or managing comorbid-associated diseases. Lately, nanotechnology has revolutionized the art of nanostructure synthesis for disease imaging, diagnosis, and treatment. Loading drugs into nanocarriers has been established as a promising strategy to extend their circulating time, particularly in treating NAFLD. In addition, considering a master modulator of adipogenesis and lysosomal biogenesis and function, designing novel nanostructures for biomedical applications requires using biodegradable materials. Various nanostructures, including inorganic nanoparticles (NPs), organic-based NPs, metallic nanocarriers, biodegradable polymeric nanocarriers, polymer-hybrid nanocarriers, and lipid-based nanocarriers have been designed for NAFLD treatment, which significantly affected serum glucose/lipid levels and liver function indices. NPs modified with polymers, bimetallic NPs, and superparamagnetic NPs have been used to design sensitive nanosensors to measure NAFLD-related biomarkers. However, certain limitations are associated with their use as diagnostic agents. The purpose of this review article is to shed light on the recent advancements in the field of nanomedicine for the early diagnosis, treatment, and prognosis of this progressive liver disease.
کلیدواژه ها:
Biomaterials ، Nanomaterials ، Drug delivery ، Nanotechnology ، Non-alcoholic fatty liver disease (NAFLD).
نویسندگان
Saman Sargazi
Zahedan University of Medical Sciences
Mahtab Ghasemi Toudeshkchouei
University of Tehran
Abbas Rahdar
University of Zabol
Aisha Rauf
Grand Asian University, Sialkot Pakistan Quaid I Azam University
Soheil Amani
Institute for Advanced Studies in Basic Sciences (IASBS)
Razieh Behzadmehr
Department of Radiology, Zabol university of medical sciences
Ana M. Diez-Pascual
Universidad de Alcalá
Francesco Baino
Politecnico di Torino
Muhammad Bilal
School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian ۲۲۳۰۰۳, China
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :